Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency

Shui-Long Guo1, Hui Ye, Yan Teng

  • 11] State Key Laboratory of Proteomics, Genetic Laboratory of Development and Disease, Institute of Biotechnology, Beijing 100071, China [2] Institute of Geriatrics, PLA Postgraduate School of Medicine, PLA General Hospital, Beijing 100853, China [3].

Nature Communications
|October 24, 2013
PubMed

Insights

Inactivating PTEN in mouse stomachs causes cancer by disrupting the p53-miR-365 pathway, increasing cell proliferation. Restoring miR-365 or Akt1 stops this gastric tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • PTEN/Akt signaling is often altered in human gastric cancers.
  • The direct role of PTEN/Akt dysregulation in gastric tumor development in vivo is unclear.

Purpose of the Study:

  • To investigate the in vivo causal link between PTEN/Akt signaling dysregulation and gastric tumorigenesis.
  • To elucidate the molecular mechanisms driving gastric cancer initiation and progression in response to PTEN loss.

Main Methods:

  • Inactivation of PTEN in mouse gastric epithelium.
  • Genetic ablation of Akt1 in PTEN-mutant mice.
  • Orthotopic restoration of miR-365.
  • Analysis of human gastric cancer tissues.

Main Results:

  • PTEN inactivation in mouse gastric epithelium led to spontaneous gastric carcinogenesis.
  • Akt activation suppressed p53, decreasing miR-365 and upregulating cyclin D1/cdc25A, promoting proliferation.
  • Genetic ablation of Akt1 or miR-365 restoration rescued tumorigenesis in PTEN-mutant mice.
  • Reduced miR-365 correlated with advanced human gastric cancer features and pathway deregulation.

Conclusions:

  • The PTEN-Akt-p53-miR-365-cyclin D1/cdc25A axis is a novel mechanism in gastric tumorigenesis.
  • This pathway represents potential therapeutic targets for gastric cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K